Jeena Sikho Lifecare Limited Has Informed the Exchange About Publication of Case Study and Case Reports.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jeena Sikho Lifecare Limited has informed the stock exchanges about the publication of three academic papers in the 'International Journal of Advanced Research (IJAR).' The publications include one case study on Ayurvedic management of chronic liver disease and two case reports covering chronic kidney disease management and Ayurvedic treatment of prostatomegaly. These were authored by the company's medical professionals, including Managing Director Manish Grover, senior consultants, and Ayurvedic experts. The company states this reflects its ongoing commitment to Ayurvedic research and evidence-based clinical practice. The filing has been made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements, 2015.
This is a research and brand-building announcement with no direct financial implications. It may slightly enhance the company's credibility in the Ayurvedic healthcare space but is unlikely to cause any meaningful movement in the stock price.